<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03612934</url>
  </required_header>
  <id_info>
    <org_study_id>SPC1</org_study_id>
    <nct_id>NCT03612934</nct_id>
  </id_info>
  <brief_title>The Impact of SPC on Advanced Breast Cancer Patients</brief_title>
  <official_title>The Influence of Specialist Palliative Care on the Exacerbation of Negative Symptoms, Life Quality and Performance Status of Patients With Advanced Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Silesian University of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Silesian University of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective, observational study is the evaluation of the effectiveness of a
      14-day Specialist Palliative Care therapy in participants with advanced breast cancer carried
      out in a stationary palliative care unit in Poland. The length of the entire study will be 36
      months.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2015</start_date>
  <completion_date type="Actual">May 1, 2018</completion_date>
  <primary_completion_date type="Actual">May 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Variation of intensification of patients negative symptoms before and after SPC</measure>
    <time_frame>14 days</time_frame>
    <description>intensification of patients negative symptoms was assessed by Edmonton Symptom Assessment System (esas)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Variation of performance status of patients before and after SPC</measure>
    <time_frame>14 days</time_frame>
    <description>performance status of patients was assessed by ECOG scale (Eastern Cooperative Oncology Group)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Variation of quality of life of patients before and after SPC</measure>
    <time_frame>14 days</time_frame>
    <description>quality of life of patients of patients was assessed by quality of life uniscale (QoLU)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">144</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Palliative Care</condition>
  <condition>Quality of Life</condition>
  <condition>Cancer, Breast</condition>
  <arm_group>
    <arm_group_label>patients under the age of 65 years</arm_group_label>
    <description>patients under the age of 65 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients at the age of 65 years and over</arm_group_label>
    <description>patients at the age of 65 years and over</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Specialist Palliative Care</intervention_name>
    <description>In the research, Specialist Palliative Care was provided according to the guidelines established by Mid-Western Health Board in a Report of the National Advisory Committee on Palliative Care as well as according to recommendations of Polish Society of Palliative Medicine and Polish National Healthcare Fund. In order to ensure interdisciplinary and integrated palliative care, a team of specialists was appointed. Team members were engaged in the process of treatment of each patient during the time of the study and applied their specialist skills according to the needs of the patients</description>
    <arm_group_label>patients at the age of 65 years and over</arm_group_label>
    <arm_group_label>patients under the age of 65 years</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with advanced stage breast cancer refered for a SPC treatment at palliative care
        department in Poland, Będzin.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        the patient's conscious consent for examination and the ability to fill in the form by the
        patient herself.

        -

        Exclusion Criteria:

          -  patients with cognitive disturbances disabling credible answers in the questionnaire,
             deceased patients or those discharged from the ward before 14 days of hospitalisation.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>33 Years</minimum_age>
    <maximum_age>91 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jadwiga Jośko-Ochojska, prof</last_name>
    <role>Study Chair</role>
    <affiliation>4. Chair and Department of Medicine and Environmental Epidemiology Medical University of Silesia in Katowice</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Łukasz Pietrzyńsi</last_name>
    <role>Principal Investigator</role>
    <affiliation>1. Medical University of Silesia, department of palliative medicine</affiliation>
  </overall_official>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 9, 2018</study_first_submitted>
  <study_first_submitted_qc>July 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2018</study_first_posted>
  <last_update_submitted>July 26, 2018</last_update_submitted>
  <last_update_submitted_qc>July 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Silesian University of Medicine</investigator_affiliation>
    <investigator_full_name>Łukasz Pietrzyński</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Breast Cancer</keyword>
  <keyword>palliative care</keyword>
  <keyword>life quality</keyword>
  <keyword>performance status</keyword>
  <keyword>esas</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>August 2, 2018</submitted>
    <returned>January 17, 2019</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

